Jerome J. Dvonch serves as Executive at Sonoma Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Jerome J. Dvonch has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jun 20, 2024 involved receiving (via award) 53,586 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Jun 20, 2024 | SNOA | $0 | Award | 53,586 | $N/A | Discretionary |
Jerome J. Dvonch currently holds 84,595 shares of Sonoma Pharmaceuticals, Inc. (SNOA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jerome J. Dvonch has been a net neutral trader of SNOA stock. They have purchased $0 and sold $0 worth of shares.
Jerome J. Dvonch's most recent insider trade was on Jun 20, 2024, when they sold 53,586 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted